| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endoribonuclease activity, cleaving miRNA-paired mRNA | 6.65e-06 | 2 | 52 | 2 | GO:0090624 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 6.45e-05 | 83 | 52 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | miRNA binding | 2.65e-04 | 48 | 52 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 5.09e-04 | 13 | 52 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 5.65e-04 | 62 | 52 | 3 | GO:0061980 | |
| GeneOntologyMolecularFunction | chloride channel regulator activity | 6.83e-04 | 15 | 52 | 2 | GO:0017081 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 7.80e-04 | 16 | 52 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 8.82e-04 | 17 | 52 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | toxic substance binding | 9.91e-04 | 18 | 52 | 2 | GO:0015643 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.10e-03 | 78 | 52 | 3 | GO:0003725 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.15e-03 | 79 | 52 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.45e-03 | 188 | 52 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.62e-03 | 23 | 52 | 2 | GO:0015464 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 3.03e-03 | 111 | 52 | 3 | GO:0003727 | |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 4.72e-08 | 4 | 48 | 3 | GO:0140766 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 4.72e-08 | 4 | 48 | 3 | GO:0090625 | |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 9.84e-07 | 9 | 48 | 3 | GO:0010501 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 1.40e-06 | 10 | 48 | 3 | GO:0070922 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 5.30e-06 | 2 | 48 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | pre-miRNA processing | 7.86e-06 | 17 | 48 | 3 | GO:0031054 | |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 1.59e-05 | 3 | 48 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 2.62e-05 | 25 | 48 | 3 | GO:2001224 | |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 3.17e-05 | 4 | 48 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | sensory processing | 5.28e-05 | 5 | 48 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 7.91e-05 | 6 | 48 | 2 | GO:0001978 | |
| GeneOntologyBiologicalProcess | positive regulation of amide metabolic process | 8.69e-05 | 37 | 48 | 3 | GO:0034250 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by baroreceptor feedback | 1.47e-04 | 8 | 48 | 2 | GO:0003025 | |
| GeneOntologyBiologicalProcess | positive regulation of CoA-transferase activity | 1.89e-04 | 9 | 48 | 2 | GO:1905920 | |
| GeneOntologyBiologicalProcess | miRNA processing | 1.90e-04 | 48 | 48 | 3 | GO:0035196 | |
| GeneOntologyBiologicalProcess | response to cold | 2.41e-04 | 52 | 48 | 3 | GO:0009409 | |
| GeneOntologyBiologicalProcess | regulation of CoA-transferase activity | 2.88e-04 | 11 | 48 | 2 | GO:1905918 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 2.88e-04 | 11 | 48 | 2 | GO:0035095 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 3.17e-04 | 57 | 48 | 3 | GO:0009299 | |
| GeneOntologyBiologicalProcess | regulation of synapse structural plasticity | 3.45e-04 | 12 | 48 | 2 | GO:0051823 | |
| GeneOntologyBiologicalProcess | regulation of neuron migration | 4.06e-04 | 62 | 48 | 3 | GO:2001222 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, dopaminergic | 4.07e-04 | 13 | 48 | 2 | GO:0032225 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 4.18e-04 | 151 | 48 | 4 | GO:0007052 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 4.26e-04 | 63 | 48 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | dendrite arborization | 5.46e-04 | 15 | 48 | 2 | GO:0140059 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 6.83e-04 | 74 | 48 | 3 | GO:0070918 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 7.05e-04 | 17 | 48 | 2 | GO:0048149 | |
| GeneOntologyCellularComponent | RISC-loading complex | 1.62e-06 | 10 | 51 | 3 | GO:0070578 | |
| GeneOntologyCellularComponent | spine apparatus membrane | 1.75e-05 | 3 | 51 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | postsynapse | FZD9 USP6 FLNA AGO2 COL13A1 ANK3 GAP43 PRRT2 CHRFAM7A CHRNA7 SLC12A5 | 2.74e-05 | 1018 | 51 | 11 | GO:0098794 |
| GeneOntologyCellularComponent | endoribonuclease complex | 1.00e-04 | 37 | 51 | 3 | GO:1902555 | |
| GeneOntologyCellularComponent | somatodendritic compartment | VGF FLNA AGO2 ANK3 GAP43 GOLGA8B PRRT2 CHRFAM7A DYNC1H1 CHRNA7 SLC12A5 | 1.49e-04 | 1228 | 51 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | endonuclease complex | 1.58e-04 | 43 | 51 | 3 | GO:1905348 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.07e-04 | 503 | 51 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | spine apparatus | 2.08e-04 | 9 | 51 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.39e-04 | 405 | 51 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | dendritic shaft | 7.85e-04 | 74 | 51 | 3 | GO:0043198 | |
| GeneOntologyCellularComponent | neuronal cell body | 8.70e-04 | 835 | 51 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 8.71e-04 | 18 | 51 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.03e-03 | 477 | 51 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | dendrite | 1.04e-03 | 858 | 51 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.05e-03 | 860 | 51 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.06e-03 | 82 | 51 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | glycinergic synapse | 1.08e-03 | 20 | 51 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | filopodium membrane | 1.19e-03 | 21 | 51 | 2 | GO:0031527 | |
| GeneOntologyCellularComponent | axolemma | 1.19e-03 | 21 | 51 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | collagen trimer | 1.30e-03 | 88 | 51 | 3 | GO:0005581 | |
| GeneOntologyCellularComponent | cholinergic synapse | 1.31e-03 | 22 | 51 | 2 | GO:0098981 | |
| GeneOntologyCellularComponent | costamere | 1.31e-03 | 22 | 51 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | main axon | 1.34e-03 | 89 | 51 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.46e-03 | 201 | 51 | 4 | GO:0099634 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.65e-03 | 523 | 51 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | cell body | 1.72e-03 | 929 | 51 | 8 | GO:0044297 | |
| GeneOntologyCellularComponent | P-body | 1.98e-03 | 102 | 51 | 3 | GO:0000932 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.85e-03 | 583 | 51 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | growth cone | 2.99e-03 | 245 | 51 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.35e-03 | 253 | 51 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | filopodium | 3.37e-03 | 123 | 51 | 3 | GO:0030175 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.92e-03 | 431 | 51 | 5 | GO:0031253 | |
| GeneOntologyCellularComponent | distal axon | 4.08e-03 | 435 | 51 | 5 | GO:0150034 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.17e-03 | 269 | 51 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 5.24e-03 | 287 | 51 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | axon | 5.63e-03 | 891 | 51 | 7 | GO:0030424 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 8.69e-03 | 332 | 51 | 4 | GO:0005788 | |
| MousePheno | airway basal cell hyperplasia | 9.24e-06 | 2 | 43 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 9.24e-06 | 2 | 43 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 9.24e-06 | 2 | 43 | 2 | MP:0011113 | |
| MousePheno | abnormal nicotine-mediated receptor currents | 5.52e-05 | 4 | 43 | 2 | MP:0009475 | |
| MousePheno | abnormal synapse morphology | 5.88e-05 | 224 | 43 | 6 | MP:0009538 | |
| MousePheno | abnormal seizure response to pharmacological agent | 8.38e-05 | 147 | 43 | 5 | MP:0000950 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 1.38e-04 | 6 | 43 | 2 | MP:0001054 | |
| MousePheno | abnormal somatosensory cortex morphology | 1.39e-04 | 33 | 43 | 3 | MP:0000859 | |
| MousePheno | abnormal spatial learning | 1.85e-04 | 276 | 43 | 6 | MP:0001463 | |
| MousePheno | abnormal parietal lobe morphology | 1.96e-04 | 37 | 43 | 3 | MP:0000794 | |
| MousePheno | abnormal brain interneuron morphology | 1.96e-04 | 37 | 43 | 3 | MP:0004101 | |
| MousePheno | abnormal neuromuscular synapse morphology | 2.02e-04 | 95 | 43 | 4 | MP:0001053 | |
| MousePheno | abnormal somatic motor system morphology | 2.27e-04 | 98 | 43 | 4 | MP:0001051 | |
| MousePheno | prolonged estrous cycle | 2.29e-04 | 39 | 43 | 3 | MP:0009006 | |
| MousePheno | abnormal GABAergic neuron physiology | 2.56e-04 | 8 | 43 | 2 | MP:0011987 | |
| MousePheno | abnormal behavioral response to xenobiotic | 3.40e-04 | 309 | 43 | 6 | MP:0009745 | |
| MousePheno | abnormal seizure response to inducing agent | 3.61e-04 | 201 | 43 | 5 | MP:0009357 | |
| MousePheno | abnormal cerebral hemisphere morphology | 4.16e-04 | 599 | 43 | 8 | MP:0008540 | |
| MousePheno | abnormal cell differentiation | 5.84e-04 | 795 | 43 | 9 | MP:0005076 | |
| MousePheno | impaired spatial working memory | 5.98e-04 | 12 | 43 | 2 | MP:0014370 | |
| MousePheno | decreased erythroblast number | 5.98e-04 | 12 | 43 | 2 | MP:0011179 | |
| MousePheno | tremors | 6.88e-04 | 353 | 43 | 6 | MP:0000745 | |
| MousePheno | seizures | 7.63e-04 | 360 | 43 | 6 | MP:0002064 | |
| Domain | Argonaute_N | 8.13e-08 | 4 | 52 | 3 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 8.13e-08 | 4 | 52 | 3 | IPR032473 | |
| Domain | ArgoL2 | 8.13e-08 | 4 | 52 | 3 | IPR032472 | |
| Domain | ArgoN | 8.13e-08 | 4 | 52 | 3 | PF16486 | |
| Domain | ArgoMid | 8.13e-08 | 4 | 52 | 3 | PF16487 | |
| Domain | ArgoL2 | 8.13e-08 | 4 | 52 | 3 | PF16488 | |
| Domain | DUF1785 | 2.03e-07 | 5 | 52 | 3 | SM01163 | |
| Domain | ArgoL1 | 4.05e-07 | 6 | 52 | 3 | PF08699 | |
| Domain | ArgoL1 | 4.05e-07 | 6 | 52 | 3 | IPR014811 | |
| Domain | PIWI | 1.13e-06 | 8 | 52 | 3 | PS50822 | |
| Domain | Piwi | 1.13e-06 | 8 | 52 | 3 | IPR003165 | |
| Domain | Piwi | 1.13e-06 | 8 | 52 | 3 | PF02171 | |
| Domain | Piwi | 1.13e-06 | 8 | 52 | 3 | SM00950 | |
| Domain | PAZ | 1.69e-06 | 9 | 52 | 3 | PS50821 | |
| Domain | PAZ_dom | 1.69e-06 | 9 | 52 | 3 | IPR003100 | |
| Domain | PAZ | 1.69e-06 | 9 | 52 | 3 | PF02170 | |
| Domain | PAZ | 1.69e-06 | 9 | 52 | 3 | SM00949 | |
| Domain | - | 3.03e-04 | 47 | 52 | 3 | 3.30.420.10 | |
| Domain | RNaseH-like_dom | 9.37e-04 | 69 | 52 | 3 | IPR012337 | |
| Domain | Collagen | 1.71e-03 | 85 | 52 | 3 | PF01391 | |
| Domain | Collagen | 1.71e-03 | 85 | 52 | 3 | IPR008160 | |
| Domain | Acetylcholine_rcpt_TM | 1.85e-03 | 23 | 52 | 2 | IPR027361 | |
| Domain | - | 1.85e-03 | 23 | 52 | 2 | 1.20.120.370 | |
| Domain | C2H2_Znf_fam | 2.02e-03 | 24 | 52 | 2 | IPR027775 | |
| Domain | Znf_C2H2-like | 6.26e-03 | 796 | 52 | 7 | IPR015880 | |
| Domain | Znf_C2H2 | 6.65e-03 | 805 | 52 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 6.78e-03 | 808 | 52 | 7 | SM00355 | |
| Domain | Neurotransmitter_ion_chnl_CS | 6.97e-03 | 45 | 52 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 7.28e-03 | 46 | 52 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 7.59e-03 | 47 | 52 | 2 | PF02931 | |
| Domain | Neur_channel | 7.59e-03 | 47 | 52 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 7.59e-03 | 47 | 52 | 2 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 7.59e-03 | 47 | 52 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 7.59e-03 | 47 | 52 | 2 | IPR006029 | |
| Domain | - | 7.59e-03 | 47 | 52 | 2 | 2.70.170.10 | |
| Domain | SCAN | 1.06e-02 | 56 | 52 | 2 | SM00431 | |
| Domain | SCAN_BOX | 1.14e-02 | 58 | 52 | 2 | PS50804 | |
| Domain | SCAN | 1.14e-02 | 58 | 52 | 2 | PF02023 | |
| Domain | SCAN_dom | 1.14e-02 | 58 | 52 | 2 | IPR003309 | |
| Domain | Retrov_capsid_C | 1.18e-02 | 59 | 52 | 2 | IPR008916 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 1.06e-07 | 5 | 32 | 3 | M22079 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 2.12e-07 | 6 | 32 | 3 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 2.12e-07 | 6 | 32 | 3 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 3.70e-07 | 7 | 32 | 3 | M46421 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 4.31e-07 | 28 | 32 | 4 | M48253 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 5.90e-07 | 8 | 32 | 3 | MM15082 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 8.84e-07 | 9 | 32 | 3 | M27340 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 8.84e-07 | 9 | 32 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 8.84e-07 | 9 | 32 | 3 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.26e-06 | 10 | 32 | 3 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 2.99e-06 | 13 | 32 | 3 | M46434 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 4.31e-06 | 49 | 32 | 4 | M48250 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 7.07e-06 | 17 | 32 | 3 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.00e-05 | 19 | 32 | 3 | M48238 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 2.36e-05 | 25 | 32 | 3 | M712 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.87e-05 | 161 | 32 | 5 | M27871 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 5.04e-05 | 32 | 32 | 3 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 5.04e-05 | 32 | 32 | 3 | M27900 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 6.06e-05 | 34 | 32 | 3 | M46422 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER | 6.62e-05 | 35 | 32 | 3 | M42525 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 7.83e-05 | 37 | 32 | 3 | M29790 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.35e-04 | 117 | 32 | 4 | M19248 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.61e-04 | 47 | 32 | 3 | M29777 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.82e-04 | 49 | 32 | 3 | MM14837 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 3.01e-04 | 58 | 32 | 3 | M11980 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.25e-04 | 12 | 32 | 2 | MM15312 | |
| Pathway | REACTOME_CA2_PATHWAY | 3.67e-04 | 62 | 32 | 3 | M27321 | |
| Pathway | REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS | 3.83e-04 | 13 | 32 | 2 | MM14616 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 3.85e-04 | 63 | 32 | 3 | M27862 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 3.98e-04 | 155 | 32 | 4 | M522 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 5.15e-04 | 15 | 32 | 2 | MM14704 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 8.94e-04 | 84 | 32 | 3 | M27495 | |
| Pathway | REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS | 1.02e-03 | 21 | 32 | 2 | M26978 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.09e-03 | 90 | 32 | 3 | M820 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 1.20e-03 | 93 | 32 | 3 | M27572 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 1.20e-03 | 93 | 32 | 3 | M42521 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 1.23e-03 | 23 | 32 | 2 | M39883 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.28e-03 | 95 | 32 | 3 | M48268 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.32e-03 | 96 | 32 | 3 | M27792 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.93e-03 | 237 | 32 | 4 | M27786 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 2.37e-03 | 32 | 32 | 2 | MM14707 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.43e-03 | 119 | 32 | 3 | M607 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 2.52e-03 | 33 | 32 | 2 | MM14666 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 2.83e-03 | 35 | 32 | 2 | M27190 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 3.62e-03 | 137 | 32 | 3 | M48232 | |
| Pathway | REACTOME_PTEN_REGULATION | 3.77e-03 | 139 | 32 | 3 | M27646 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.77e-03 | 139 | 32 | 3 | M715 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 3.87e-03 | 41 | 32 | 2 | M29748 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.87e-03 | 41 | 32 | 2 | MM15538 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 4.33e-03 | 146 | 32 | 3 | M27288 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.45e-03 | 44 | 32 | 2 | M27812 | |
| Pubmed | ZNF609 KMT2D IRS4 AGO2 AGO3 NFKBIB ZSCAN18 ZBTB40 IRF3 TAF2 GPATCH8 MIDEAS NIPBL RBM20 DYNC1H1 NPAT | 2.14e-10 | 1429 | 53 | 16 | 35140242 | |
| Pubmed | Sequential interplay of nicotinic and GABAergic signaling guides neuronal development. | 3.34e-09 | 3 | 53 | 3 | 17158331 | |
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 1.34e-08 | 4 | 53 | 3 | 23748378 | |
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 1.34e-08 | 4 | 53 | 3 | 15260970 | |
| Pubmed | Argonaute proteins: potential biomarkers for human colon cancer. | 1.34e-08 | 4 | 53 | 3 | 20146808 | |
| Pubmed | Slicing-independent RISC activation requires the argonaute PAZ domain. | 1.34e-08 | 4 | 53 | 3 | 22795694 | |
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 19966796 | ||
| Pubmed | Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. | 1.34e-08 | 4 | 53 | 3 | 18771919 | |
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 12526743 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 19393748 | ||
| Pubmed | Differential expression of components of the microRNA machinery during mouse organogenesis. | 3.33e-08 | 5 | 53 | 3 | 16036130 | |
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 12414724 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 19324964 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.16e-07 | 7 | 53 | 3 | 19470757 | |
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 34907157 | ||
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 19536157 | ||
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 19383768 | ||
| Pubmed | 1.36e-07 | 549 | 53 | 9 | 38280479 | ||
| Pubmed | Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis. | 1.86e-07 | 8 | 53 | 3 | 19345100 | |
| Pubmed | 1.86e-07 | 8 | 53 | 3 | 29021386 | ||
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 2.79e-07 | 9 | 53 | 3 | 12906857 | |
| Pubmed | Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs. | 1.85e-06 | 16 | 53 | 3 | 20102707 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 38070724 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19626424 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17012698 | ||
| Pubmed | Cholinergic Pathway Suppresses Pulmonary Innate Immunity Facilitating Pneumonia After Stroke. | 2.28e-06 | 2 | 53 | 2 | 26451017 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 34453977 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24757672 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26999808 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27129924 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17291692 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 2.28e-06 | 2 | 53 | 2 | 23521765 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 28258105 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19344760 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 35926661 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17640819 | ||
| Pubmed | Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. | 2.28e-06 | 2 | 53 | 2 | 23431157 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29114104 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33995108 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32552811 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24836856 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 31904546 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15948184 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 35678315 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33117372 | ||
| Pubmed | Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. | 2.28e-06 | 2 | 53 | 2 | 12628457 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25157794 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19615981 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 38944290 | ||
| Pubmed | Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice. | 2.28e-06 | 2 | 53 | 2 | 28243714 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 31202708 | ||
| Pubmed | Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. | 2.28e-06 | 2 | 53 | 2 | 22246862 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24298024 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29975102 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29580318 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 35479080 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 38597441 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27471776 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22688057 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22820264 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33953172 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32028688 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30089821 | ||
| Pubmed | Nicotinic acetylcholine receptor activation reduces skeletal muscle inflammation of mdx mice. | 2.28e-06 | 2 | 53 | 2 | 20615555 | |
| Pubmed | Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype. | 2.28e-06 | 2 | 53 | 2 | 15896732 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30429582 | ||
| Pubmed | A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons. | 2.28e-06 | 2 | 53 | 2 | 21501254 | |
| Pubmed | α7-cholinergic receptor mediates vagal induction of splenic norepinephrine. | 2.28e-06 | 2 | 53 | 2 | 21339364 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21368056 | ||
| Pubmed | Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice. | 2.28e-06 | 2 | 53 | 2 | 24289814 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19949071 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 1400473 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17204496 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26937017 | ||
| Pubmed | α7 nicotinic receptors play a role in regulation of cardiac hemodynamics. | 2.28e-06 | 2 | 53 | 2 | 37017608 | |
| Pubmed | Impaired hippocampal theta oscillations in the mice null alpha7 nicotinic acetylcholine receptors. | 2.28e-06 | 2 | 53 | 2 | 23795917 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 36603528 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20592195 | ||
| Pubmed | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production. | 2.28e-06 | 2 | 53 | 2 | 26650489 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11854451 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22848433 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23842742 | ||
| Pubmed | Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors. | 2.28e-06 | 2 | 53 | 2 | 17292512 | |
| Pubmed | Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. | 2.28e-06 | 2 | 53 | 2 | 16650968 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 35413868 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23637989 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 9782083 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24462939 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29261717 | ||
| Pubmed | Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. | 2.28e-06 | 2 | 53 | 2 | 18199426 | |
| Pubmed | Stroke-induced activation of the α7 nicotinic receptor increases Pseudomonas aeruginosa lung injury. | 2.28e-06 | 2 | 53 | 2 | 22490926 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 36997969 | ||
| Pubmed | A phenotype for the alpha 7 nicotinic acetylcholine receptor null mutant. | 2.28e-06 | 2 | 53 | 2 | 15364017 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23769729 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15944242 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23270857 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18077004 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19462340 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 16923147 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11790782 | ||
| Interaction | TLE3 interactions | 3.79e-07 | 376 | 51 | 9 | int:TLE3 | |
| Interaction | RNF41 interactions | 3.52e-06 | 164 | 51 | 6 | int:RNF41 | |
| Interaction | FEV interactions | 1.20e-05 | 203 | 51 | 6 | int:FEV | |
| Interaction | TDRD1 interactions | 1.44e-05 | 19 | 51 | 3 | int:TDRD1 | |
| Interaction | PHF21A interactions | 2.37e-05 | 343 | 51 | 7 | int:PHF21A | |
| Interaction | RCOR1 interactions | 3.11e-05 | 494 | 51 | 8 | int:RCOR1 | |
| Interaction | ALG13 interactions | 9.79e-05 | 183 | 51 | 5 | int:ALG13 | |
| Interaction | KDM1A interactions | 1.05e-04 | 941 | 51 | 10 | int:KDM1A | |
| Interaction | SP7 interactions | 1.14e-04 | 304 | 51 | 6 | int:SP7 | |
| Interaction | SMG7 interactions | 1.48e-04 | 319 | 51 | 6 | int:SMG7 | |
| Interaction | NUP43 interactions | 1.61e-04 | 625 | 51 | 8 | int:NUP43 | |
| Interaction | EN1 interactions | 1.72e-04 | 110 | 51 | 4 | int:EN1 | |
| Interaction | PAX8 interactions | 1.78e-04 | 111 | 51 | 4 | int:PAX8 | |
| Cytoband | 1p34 | 6.34e-04 | 32 | 53 | 2 | 1p34 | |
| Cytoband | 15q14 | 1.49e-03 | 49 | 53 | 2 | 15q14 | |
| GeneFamily | Argonaute/PIWI family | 3.08e-07 | 8 | 33 | 3 | 408 | |
| GeneFamily | Collagens | 3.18e-03 | 46 | 33 | 2 | 490 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-06 | 194 | 53 | 5 | 5bd0f739aa75f387cca7c3b2686493ee2d1ee968 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.98e-06 | 200 | 53 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.03e-05 | 135 | 53 | 4 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.13e-05 | 162 | 53 | 4 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 59 | 53 | 3 | 74590437b1d9a2a8fe56d79b2e66803528b81298 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 173 | 53 | 4 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 175 | 53 | 4 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 177 | 53 | 4 | 0e9e44119653abfd270e602e5e477a15e774638f | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 177 | 53 | 4 | c2b8a3a149d70f77612759dea34df9e43953c566 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 177 | 53 | 4 | 384f841aa7b2d05815af7885e481f5affc55d897 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.09e-05 | 179 | 53 | 4 | b0585a8e596c3d8e434af943e65207fa5877600d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.36e-05 | 181 | 53 | 4 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | Control-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.07e-05 | 186 | 53 | 4 | 80f6f25dbe3c5efe4bc350f5d2eb990c38aab338 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.22e-05 | 187 | 53 | 4 | a748b3a59e398e0da019db3f16d38adb1960c29f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-05 | 189 | 53 | 4 | 3f5522be3e24dcdb6272f18cee2f239dfdeff9ad | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 7.52e-05 | 189 | 53 | 4 | 14e8e57e4db336fbef005270647983b4edf407c0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.99e-05 | 192 | 53 | 4 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 193 | 53 | 4 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | Control-B_memory-0|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.15e-05 | 193 | 53 | 4 | b8d64cc0abc4a3311e172e7e48a7de0f2188effb | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.65e-05 | 196 | 53 | 4 | 3a8bd09a09c19df27c954d448f1bae945314c221 | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | 8.83e-05 | 197 | 53 | 4 | 7d19b93d6853828e2a036e37c4887edb1de4503c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-05 | 198 | 53 | 4 | 328f1d5d8168e05edd301d3a0f2eb5c6cd1c67c8 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 9.00e-05 | 198 | 53 | 4 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|T_cell / Lineage, cell class and subclass | 9.00e-05 | 198 | 53 | 4 | 6773c6043ef4a3d9e9700330b6386431ee66abdc | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.00e-05 | 198 | 53 | 4 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | c7e33057466915d4e2b34f2062b22d9cdffa69dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.36e-05 | 200 | 53 | 4 | 51d20543a9c9330c34c085d9290a1fc8b5bff0d4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.19e-04 | 80 | 53 | 3 | 5c39136f5f855efbf61e1f5348ea97ea2130b241 | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; HL60; HT_HG-U133A | 6.02e-06 | 199 | 52 | 6 | 2392_UP | |
| Drug | NSC750927 | 1.44e-05 | 232 | 52 | 6 | CID000003461 | |
| Drug | gemcitabine | 3.39e-05 | 270 | 52 | 6 | ctd:C056507 | |
| Drug | bifemelane | 3.94e-05 | 29 | 52 | 3 | CID000002377 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 4.78e-05 | 174 | 52 | 5 | 1302_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.62e-05 | 180 | 52 | 5 | 4541_DN | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.73e-05 | 187 | 52 | 5 | 6902_UP | |
| Drug | quinoxaline-2-carboxylic acid | 7.61e-05 | 36 | 52 | 3 | CID000096695 | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 7.63e-05 | 192 | 52 | 5 | 3318_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; PC3; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 6727_UP | |
| Drug | Atovaquone [95233-18-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 4786_UP | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; HL60; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 3054_UP | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; HL60; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 2443_DN | |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | 8.61e-05 | 197 | 52 | 5 | 371_DN | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 7483_DN | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 4977_DN | |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; PC3; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 3687_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 7034_DN | |
| Drug | Prostaglandin E1; Down 200; 10uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 6576_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 7148_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 7439_UP | |
| Disease | Phyllodes Tumor | 3.04e-05 | 5 | 52 | 2 | C0010701 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.04e-05 | 5 | 52 | 2 | C0600066 | |
| Disease | cognitive disorder (implicated_via_orthology) | 4.55e-05 | 6 | 52 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 4.55e-05 | 6 | 52 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | reticulocyte count | ZNF469 C5orf67 AHNAK EMID1 ZBTB40 TAF2 PPP1R15A MIDEAS SLC12A5 | 7.91e-05 | 1045 | 52 | 9 | EFO_0007986 |
| Disease | Mental Retardation, Psychosocial | 1.07e-04 | 139 | 52 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 1.07e-04 | 139 | 52 | 4 | C0020796 | |
| Disease | Mental deficiency | 1.07e-04 | 139 | 52 | 4 | C0917816 | |
| Disease | protein CREG1 measurement | 1.09e-04 | 9 | 52 | 2 | EFO_0801937 | |
| Disease | irritable bowel syndrome symptom measurement | 1.49e-04 | 58 | 52 | 3 | EFO_0021536 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.99e-04 | 12 | 52 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 1.99e-04 | 12 | 52 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Mood Disorders | 2.22e-04 | 168 | 52 | 4 | C0525045 | |
| Disease | Petit mal status | 2.28e-04 | 67 | 52 | 3 | C0270823 | |
| Disease | Grand Mal Status Epilepticus | 2.28e-04 | 67 | 52 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 2.28e-04 | 67 | 52 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.28e-04 | 67 | 52 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.28e-04 | 67 | 52 | 3 | C0751523 | |
| Disease | Complex Partial Status Epilepticus | 2.28e-04 | 67 | 52 | 3 | C0393734 | |
| Disease | Status Epilepticus | 2.39e-04 | 68 | 52 | 3 | C0038220 | |
| Disease | refractive error | 2.71e-04 | 326 | 52 | 5 | MONDO_0004892 | |
| Disease | reticulocyte measurement | 4.78e-04 | 1053 | 52 | 8 | EFO_0010700 | |
| Disease | hair colour measurement | 7.22e-04 | 615 | 52 | 6 | EFO_0007822 | |
| Disease | Seizures, Focal | 8.29e-04 | 104 | 52 | 3 | C0751495 | |
| Disease | Epilepsy | 9.50e-04 | 109 | 52 | 3 | C0014544 | |
| Disease | Intellectual Disability | 1.13e-03 | 447 | 52 | 5 | C3714756 | |
| Disease | Bipolar Disorder | 1.50e-03 | 477 | 52 | 5 | C0005586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGPKLGEERPKPHAG | 71 | Q6ZW13 | |
| HAGEKGDPGPPGDHE | 591 | P53420 | |
| KGNKGDPASHFGPPG | 1071 | P53420 | |
| EGAAVKETPHSPPGG | 341 | Q6JBY9 | |
| KETPHSPPGGVKGGD | 346 | Q6JBY9 | |
| PDIDIHGPEGKLKGP | 4101 | Q09666 | |
| GADVTHPPAGDGKKP | 596 | Q9H9G7 | |
| LGADVTHPPAGDGKK | 586 | Q9HCK5 | |
| LHGGQPPEGDPDLAK | 421 | P36544 | |
| ADVTHPPAGDGKKPS | 596 | Q9UKV8 | |
| PHPDDSGKEDGLGPK | 796 | Q5T481 | |
| PGSGAGEKHKEEPID | 1271 | Q14207 | |
| PPNPKHAKTKEAGDG | 86 | O60829 | |
| GKEFEPKAAHPVPGS | 86 | A6NK44 | |
| HGAPEPEGEDEKSGP | 296 | Q15653 | |
| PAGKESQEGPKHPTG | 521 | Q9UKJ3 | |
| EEEGTQGHPDGTPPK | 746 | Q14005 | |
| HPETPKQKGDGRPET | 721 | Q6KC79 | |
| DVDFPSPGPHGGDKE | 3531 | P98088 | |
| LHGGQPPEGDPDLAK | 331 | Q494W8 | |
| ESPKVPGEGPGHSEA | 16 | Q7Z6L0 | |
| PENATAGPAEPHKGL | 156 | O00144 | |
| GAGGEEGEHVKPFKP | 16 | Q96EW2 | |
| KLPGDGGSVPEKGKH | 66 | F2Z3F1 | |
| QHGAPGPGPADASKV | 2546 | P21333 | |
| QHGPDGQGFPKAEEK | 2651 | Q12955 | |
| GKGPEQNPAEHKPSV | 551 | Q6PJG2 | |
| DAPQVSHKPGGEPKI | 941 | Q14204 | |
| RGEPGPKGDPGEKSH | 356 | Q96A84 | |
| KGENGHPGSPGEKGE | 526 | Q5TAT6 | |
| PGAPAPQELGAADKH | 521 | A8MQT2 | |
| VPEENKPPSRHAGGK | 516 | Q9HBR0 | |
| SDHGGKPPLPAEKPA | 646 | Q9HBR0 | |
| HKETGKGEAAPGPQS | 276 | O75807 | |
| PRHLPGEDVKGDGNP | 31 | Q9H2X9 | |
| PNSGHGPDGEVPKDK | 301 | Q14653 | |
| KPGDGGSPSKPSDHE | 866 | O14654 | |
| AGGHGEDRPEPLSPK | 366 | Q9NZT2 | |
| GEHPSAAAPGPGKHK | 86 | Q8IZ73 | |
| PKGDKAEDGFHGVSP | 201 | Q8NBJ7 | |
| DPAGPGDSKNPGDAK | 56 | Q96IW2 | |
| PDSGPLPETHKFGEG | 236 | O15240 | |
| APATGSKPDEPGKAG | 91 | P17677 | |
| PIFGGGKEKDNPASH | 416 | Q6P1X5 | |
| HPETKPGSLDGDGAP | 596 | Q32MQ0 | |
| GPAGPVSHPDGQEAK | 336 | A6NJL1 | |
| KSGPGKAKEPGADPA | 1061 | O15014 | |
| GSKGEHPEGDPGEVP | 476 | O95359 | |
| AGAGDPGKQQAPEKP | 1136 | O95359 | |
| FKAQGPPKPNTDEGG | 451 | Q5VIR6 | |
| QGPHGSLGPKEKGES | 3771 | Q96JG9 | |
| KLGTKRPHPEDGDGQ | 366 | Q8TBC5 | |
| KGPGAAVEPNGHPEA | 641 | Q5QJ38 | |
| HRAGLPEDKGPEPVG | 26 | P35125 | |
| LEAHGAGGEPDAPKK | 786 | Q9NUA8 | |
| GPAGELHAKVPSGQP | 2501 | O14686 | |
| APGPLEDKGLGTPEH | 46 | P15173 |